Clinical Trial Update: Trimodal Therapy Plus Atezolizumab in Muscle-invasive Bladder Cancer [Phase 2]

View source ↗

Summary

Phase 2 study investigating trimodal therapy with atezolizumab in muscle-invasive bladder cancer; status is unknown. Focuses on safety issues.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Muscle-invasive Bladder Cancer

Drugs mentioned

• Atezolizumab (atezolizumab)

Snippet

Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre | Conditions: Safety Issues | Phase 2 | Status: UNKNOWN